Filing Details

Accession Number:
0001181431-11-017661
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-03-14 12:25:49
Reporting Period:
2011-03-10
Filing Date:
2011-03-14
Accepted Time:
2011-03-14 12:25:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1338042 Aegerion Pharmaceuticals Inc. AEGR Pharmaceutical Preparations (2834) 202960116
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1378585 David Scheer C/O Scheer Investment Holdings Vii Llc
555 Long Wharf Drive, 11Th Floor
New Haven CT 06511
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-03-10 3,994 $15.11 644,148 No 4 P Direct
Common Stock Acquisiton 2011-03-11 6,006 $15.36 650,154 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 640,154 Indirect See Footnote
Footnotes
  1. Mr. Scheer is the managing member of Scheer Investment Holdings VII LLC. Mr. Scheer disclaims beneficial ownership except to the extent of his proportionate pecuniary interest therein.